Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004733 · ClinicalTrials.gov registry record · Phase 3
Timing of Levodopa Treatment in Parkinson's Disease
A Phase 3 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00004733: Completed Phase 3 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00004733 is a Phase 3 study that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004733, a Phase 3 study, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The ELLDOPA study is a controlled clinical trial in patients with newly diagnosed PD to determine the optimal timing and dosing with levodopa (Sinemet or its generic equivalents).
Interventions
- DRUG levodopa
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-01 |
| Est. Completion | 2004-02 |
| Phase | Phase 3 |
What the finished NCT00004733 record still lists
NCT00004733 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which levodopa is the first listed.
NCT00004733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004733 about?
NCT00004733 is a clinical study titled "Timing of Levodopa Treatment in Parkinson's Disease". The ELLDOPA study is a controlled clinical trial in patients with newly diagnosed PD to determine the optimal timing and dosing with levodopa (Sinemet or its generic equivalents).
What is the current status of trial NCT00004733?
This trial is currently completed. It is a Phase 3 study. The study started on 1998-01. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00004733?
The interventions under investigation include: levodopa (DRUG).
Who is sponsoring clinical trial NCT00004733?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia